{"id":4183,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2000-07-14","marketCap":1028.63,"name":"Cassava Sciences Inc","phone":"15125012444.0","outstanding":42.17,"symbol":"SAVA","website":"https://www.cassavasciences.com/","industry":"Pharmaceuticals"},"price":28.880026,"year":2024,"month":8,"day":8,"weekday":"Thursday","title":"The Impact of Currency Fluctuations on Cassava Sciences Inc Multinational Stock","date":"2024-08-08","url":"/posts/2024/08/08/SAVA","content":[{"section":"Introduction","text":"Currency fluctuations can have a significant impact on multinational companies such as Cassava Sciences Inc. As a company that operates in multiple countries and deals with international trade, it is exposed to currency risk. Fluctuations in exchange rates can affect the company's financial performance and the value of its stock."},{"section":"Case Study 1: Cassava Sciences Inc and the Euro","text":"In 2019, Cassava Sciences Inc, a US-based biotech company, expanded its operations into the European market. As the euro weakened against the US dollar, the company's revenues generated in euros were worth less when converted back into dollars. This currency fluctuation had a negative impact on the company's financial results and led to a decline in its stock price."},{"section":"Case Study 2: Cassava Sciences Inc and the Chinese Yuan","text":"In 2020, Cassava Sciences Inc entered into a partnership with a Chinese pharmaceutical company. However, due to tensions between the US and China and fluctuations in the Chinese yuan, the value of the partnership became uncertain. Investors became cautious, leading to a decrease in the stock price of Cassava Sciences Inc."},{"section":"Balanced Assessment of Currency Risk","text":"Currency risk is a double-edged sword for multinational companies. On one hand, currency fluctuations can create additional costs or reduce revenues, impacting profitability and stock performance. On the other hand, currency movements can also present opportunities for companies that strategically manage their currency exposure. For example, if a company has a natural hedge or actively hedges its currency exposures, it can mitigate the negative impact of currency fluctuations and potentially benefit from favorable movements."},{"section":"Conclusion","text":"Currency fluctuations can significantly impact Cassava Sciences Inc's multinational stock. The real-world case studies demonstrate the potential negative effects of currency risk on the company's financial performance and stock price. However, a balanced assessment acknowledges that with proper currency risk management strategies, multinational companies can mitigate the impact of currency fluctuations and even capitalize on favorable movements."}],"tags":["CrossOver21","Long","Pharmaceuticals"],"news":[{"category":"company","date":1723104128,"headline":"Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates","id":129231838,"image":"","symbol":"SAVA","publisher":"Finnhub","summary":"$207.3 Million in Cash and Cash Equivalents at June 30, 2024.Company in Advanced Discussions to Resolve SEC Investigation. $40 Million Estimated Loss Contingency Recorded in Q2 for...","url":"https://finnhub.io/api/news?id=efae9ec608f9bb2620d48e3081127c1ce639b14284249996efbcb29e66ddedf3"},{"category":"company","date":1723025880,"headline":"Biotech Alert: Searches spiking for these stocks today","id":129204778,"image":"","symbol":"SAVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3590109854"},{"category":"company","date":1722948600,"headline":"Market Whales and Their Recent Bets on SAVA Options","id":129185558,"image":"","symbol":"SAVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588533165"},{"category":"company","date":1722934920,"headline":"Cassava Sciences News: Why Is SAVA Stock Trending Today?","id":129185559,"image":"","symbol":"SAVA","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588222722"},{"category":"company","date":1722930300,"headline":"Largest borrow rate increases among liquid names","id":129178198,"image":"","symbol":"SAVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3588124444"},{"category":"company","date":1722872998,"headline":"Biotech firm drops defamation suit against short-sellers after researcher charged","id":129156496,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"SAVA","publisher":"Yahoo","summary":"Cassava Sciences ended its defamation lawsuit against four short sellers who expressed doubts about its experimental Alzheimer's drug after a medical professor whose research underpinned the treatment was charged with fraud.  The biotechnology company sued in 2022 after the short sellers, who were also scientists who investigated Cassava's statements about its simufilam drug, claimed on social media and the website \"cassavafraud.com\" that Hoau-Yan Wang's research for simufilam was fabricated.  Cassava dropped the lawsuit in a Friday evening filing in federal court in Manhattan.","url":"https://finance.yahoo.com/news/biotech-firm-drops-defamation-suit-154958906.html"},{"category":"company","date":1722862860,"headline":"Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson","id":129156497,"image":"https://s.yimg.com/ny/api/res/1.2/sjuFUQg1K1J1QPFjekLaqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://media.zenfs.com/en/globenewswire.com/21979d6015cfbdfe43b479a193b60718","symbol":"SAVA","publisher":"Yahoo","summary":"AUSTIN, Texas, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today reflected on the passing of long-time board member Sanford Robertson. We are profoundly saddened by the passing of our dear friend and colleague, Sandy Robertson. Sandy served on the Board of Directors of Cassava Sciences since its inception as a public company in 1998. Sandy's commitment to Cassava’s mission and success was unwavering. Sandy’s success in the business world is well recognized by the hund","url":"https://finance.yahoo.com/news/cassava-sciences-mourns-death-board-130100573.html"},{"category":"company","date":1722860760,"headline":"Cassava Sciences call volume above normal and directionally bullish","id":129164763,"image":"","symbol":"SAVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3586854937"},{"category":"company","date":1722848460,"headline":"Cassava Sciences Mourns the Death of Board Member Sanford ?Sandy? Robertson","id":129164764,"image":"","symbol":"SAVA","publisher":"GlobeNewswire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=q8rw326bud"},{"category":"company","date":1722845280,"headline":"Cassava Sciences announces passing of board member Sanford Robertson","id":129164766,"image":"","symbol":"SAVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3586560873"},{"category":"company","date":1722755040,"headline":"Earnings week ahead: Disney, Duke Energy, Palantir, Shopify, Uber and more","id":129141881,"image":"","symbol":"SAVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3585732533"},{"category":"company","date":1722600240,"headline":"Cassava Sciences options imply 12.0% move in share price post-earnings","id":129122095,"image":"","symbol":"SAVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583511948"},{"category":"company","date":1722597420,"headline":"(SAVA) - Analyzing Cassava Sciences's Short Interest","id":129122096,"image":"","symbol":"SAVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583448121"},{"category":"company","date":1722578160,"headline":"Get Your Money Out of These 3 Healthcare Stocks ASAP","id":129108544,"image":"","symbol":"SAVA","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583050682"},{"category":"company","date":1722515400,"headline":"Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET","id":129070542,"image":"https://s.yimg.com/ny/api/res/1.2/sjuFUQg1K1J1QPFjekLaqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://media.zenfs.com/en/globenewswire.com/21979d6015cfbdfe43b479a193b60718","symbol":"SAVA","publisher":"Yahoo","summary":"AUSTIN, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it will hold a conference call on Thursday, August 8th at 8:30 a.m. Eastern Time. Event details follow:Date:Thursday, August 8thTime: 8:30 a.m. Eastern TimeAudio Webcast:https://www.CassavaSciences.com/company-presentationsOr Audio Webcast:https://edge.media-server.com/mmc/p/zjvmjjcr A replay of the audio webcast will","url":"https://finance.yahoo.com/news/cassava-sciences-hold-conference-call-123000379.html"},{"category":"company","date":1722501006,"headline":"Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8: 30 am ET","id":129063980,"image":"","symbol":"SAVA","publisher":"Finnhub","summary":"AUSTIN, Texas, Aug. 01, 2024 -- Cassava Sciences, Inc. , a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it will hold a conference call on Thursday,...","url":"https://finnhub.io/api/news?id=60414de8ed97a72178e158f201c6ed91c4f4f883d601d805d0069c3922a39d17"},{"category":"company","date":1722485820,"headline":"Interesting SAVA Put And Call Options For December 20th","id":129091079,"image":"","symbol":"SAVA","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3581905617"},{"category":"company","date":1722484680,"headline":"8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803%","id":129086644,"image":"","symbol":"SAVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3581860711"},{"category":"company","date":1722476040,"headline":"Cassava Sciences options imply 15.1% move in share price post-earnings","id":129091081,"image":"","symbol":"SAVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3581608296"},{"category":"company","date":1722427740,"headline":"Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA  And Other Big Stocks Moving Higher On Wednesday","id":129037180,"image":"","symbol":"SAVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3579497960"},{"category":"company","date":1722397260,"headline":"SAVA Makes Bullish Cross Above Critical Moving Average","id":129050936,"image":"","symbol":"SAVA","publisher":"Market News Video","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3579827822"},{"category":"company","date":1722341700,"headline":"Cassava Sciences Announces Expansion of Open-Label Extension Trials","id":129002614,"image":"https://s.yimg.com/ny/api/res/1.2/sjuFUQg1K1J1QPFjekLaqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://media.zenfs.com/en/globenewswire.com/21979d6015cfbdfe43b479a193b60718","symbol":"SAVA","publisher":"Yahoo","summary":"Ongoing open-label extension trials of simufilam in Alzheimer’s disease to be extended by up to an additional 36 months. The extension provides participants the opportunity to continue on treatment, if they desire, pending results of the ongoing pivotal Phase 3 trials. Company plans to add cognition and plasma biomarker monitoring to the open-label extension trials to gather additional long-term data on simufilam treatment. AUSTIN, Texas, July 30, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc.","url":"https://finance.yahoo.com/news/cassava-sciences-announces-expansion-open-121500799.html"},{"category":"company","date":1722340980,"headline":"SmartRent (SMRT) Stock Plunges 21% as CEO Steps Down","id":129009355,"image":"","symbol":"SAVA","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577875251"},{"category":"company","date":1722340080,"headline":"Microsoft Office Outage: Microsoft Investigates Applications, Services Issue","id":129005565,"image":"","symbol":"SAVA","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577854524"},{"category":"company","date":1722339420,"headline":"SAVA Stock: Cassava Sciences Extends Simufilam Trials as Much as 36 Months","id":129009357,"image":"","symbol":"SAVA","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577841116"},{"category":"company","date":1722328800,"headline":"Unusually active option classes on open July 30th","id":129004858,"image":"","symbol":"SAVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577626912"},{"category":"company","date":1722325800,"headline":"Cassava Sciences extends Alzheimer’s drug trials by up to 36 months","id":129009360,"image":"","symbol":"SAVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577571234"},{"category":"company","date":1722325140,"headline":"Cassava Sciences extends Simufilam Alzheimer’s trials by up to 36 months","id":129009361,"image":"","symbol":"SAVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577561470"},{"category":"company","date":1722171600,"headline":"Get Your Money Out of These 3 Biotech Stocks Before the End of July","id":129136060,"image":"https://media.zenfs.com/en/investorplace_417/7bb0fe2e42d5e10717d42c6cfa18869c","symbol":"SAVA","publisher":"Yahoo","summary":"Biotech stocks are known for their high volatility and potential for massive gains. The success in the sector often hinges on progressive and often groundbreaking medical advancements. Any concerns relating to upcoming drugs can have severely negative effects on stock prices. As per Precedence Research, the global biotechnology market is projected to grow from $1.38 trillion in 2023 to approximately $4.25 trillion by 2033. The expected growth is largely to be driven by advancements in various bi","url":"https://finance.yahoo.com/news/money-3-biotech-stocks-end-130000945.html"},{"category":"company","date":1721902380,"headline":"September 6th Options Now Available For Cassava Sciences (SAVA)","id":128913164,"image":"","symbol":"SAVA","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3571466315"}]}